About

Overview

The Cerulean team is committed to developing products to improve treatment options for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations.